The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies
Abstract
Synapse loss precedes cell death in Alzheimer's disease, but the timing of axon degeneration relative to these events, and the causal relationships remain unclear. Axons become so severely dystrophic near amyloid plaques that their interruption, causing permanent loss of function, extensive synapse loss, and potentially cell death appears imminent. However, it remains unclear whether axons are truly interrupted at plaques and whether cell bodies fail to support their axons and dendrites. We traced TgCRND8 mouse axons longitudinally through, distal to, and proximal from dystrophic regions. The corresponding neurons not only survived but remained morphologically unaltered, indicating absence of axonal damage signalling or a failure to respond to it. Axons, no matter how dystrophic, remained continuous and initially morphologically normal outside the plaque region, reflecting support by metabolically active cell bodies and continued axonal transport. Immunochemical and ultrastructural studies showed dystrophic axons were tightly associated with disruption of presynaptic transmission machinery, suggesting local functional impairment. Thus, we rule out long-range degeneration axons or dendrites as major contributors to early synapse loss in this model, raising the prospect of a therapeutic window for functional rescue of individual neurons lasting months or even years after their axons become highly dystrophic. We propose that multi-focal pathology has an important role in the human disease in bringing about the switch from local, and potentially recoverable, synapse loss into permanent loss of neuronal processes and eventually their cell bodies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another important factor might be the disruption of fast axonal transport, resulting in focal swellings filled with various organelles, as seen in the vicinity but also distant from plaques in several AD transgenic models [27,28,29,30], resembling Wallerian degeneration [31].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [27]
In the citing paper
“CRND8 APP mice reveal reduced synaptic markers and hippocampal neuronal loss at 6 months, when overlaps are first detected with cluster B modules (Adalbert et al., 2009; Brautigam et al., 2012).”
From Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models (2020) · cites this paper as Adalbert et al., 2009
In the citing paper
“Dysfunction of the endosomallysosomal system is also directly linked with Aβ deposition (Lee et al., 2022), oxidative stress (Wendt et al., 2022), and synaptic dysfunction (Adalbert et al., 2009).”
From Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease (2024) · cites this paper as Adalbert et al., 2009
In the citing paper
“However, these dystrophic neurites are not entirely disrupted (Adalbert et al., 2009), suggesting that restoration of trafficking could still result in neuroprotective benefit.”
From Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease (2024) · cites this paper as Adalbert et al., 2009
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP
Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., Nerbonne, J. M., Lichtman, J. W., & Sanes, J. R. (2000) · Neuron · doi:10.1016/s0896-6273(00)00084-2 · Cited by 3,042
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955
Axon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819
Self-citationAxotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats
Berkelaar, M., Clarke, D., Wang, Y., Bray, G., & Aguayo, A. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04368.1994 · Cited by 814
Flagged first, then by citations
Cited by
Sorted by citations
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
Lasagna‐Reeves, C. A., Castillo‐Carranza, D. L., Sengupta, U., Sarmiento, J., Troncoso, J., Jackson, G. R., & Kayed, R. (2012) · The FASEB Journal · doi:10.1096/fj.11-199851 · Cited by 527
Lee, S., Satō, Y., & Nixon, R. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6412-10.2011 · Cited by 478
Deciphering the mechanism underlying late-onset Alzheimer disease
Krstic, D., & Knuesel, I. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.236 · Cited by 457
Wallerian Degeneration, WldS, and Nmnat
Coleman, M. P., & Freeman, M. R. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153248 · Cited by 473
Gowrishankar, S., Yuan, P., Wu, Y., Schrag, M., Paradise, S., Grutzendler, J., De Camilli, P., & Ferguson, S. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510329112 · Cited by 406
Wan, Y.-W., Al-Ouran, R., Mangleburg, C. G., Perumal, T. M., Lee, T. V., Allison, K., Swarup, V., Funk, C. C., Gaiteri, C., Allen, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107908 · Cited by 295
“For example, CRND8 APP mice reveal reduced synaptic markers and hippocampal neuronal loss at 6 months, when overlaps are first detected with cluster B modules (Adalbert et al., 2009; Brautigam et al., 2012).”
BackgroundNeuroprotection and repair in multiple sclerosis
Franklin, R. J. M., ffrench‐Constant, C., Edgar, J. M., & Smith, K. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.200 · Cited by 285
Kandalepas, P. C., Sadleir, K. R., Eimer, W. A., Zhao, J., Nicholson, D. A., & Vassar, R. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1152-3 · Cited by 240
Analyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities
Dorostkar, M. M., Zou, C., Blazquez-Llorca, L., & Herms, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1449-5 · Cited by 235
Sanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0896-x · Cited by 222
Dendritic Spine Pathology in Neurodegenerative Diseases
Herms, J., & Dorostkar, M. M. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044216 · Cited by 201
Mitochondria as a central sensor for axonal degenerative stimuli
Court, F. A., & Coleman, M. P. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.04.001 · Cited by 201
Porrero, C., Rubio‐Garrido, P., Avendaño, C., & Clascá, F. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.061 · Cited by 191
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
Autophagy and Neuronal Cell Death in Neurological DisordersPreprint
Nixon, R. A., & Yang, D.-S. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008839 · Cited by 183
Review: Axon pathology in age‐related neurodegenerative disorders
Adalbert, R., & Coleman, M. P. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01308.x · Cited by 176
PLD3 affects axonal spheroids and network defects in Alzheimer’s disease
Yuan, P., Zhang, M., Tong, L., Morse, T. M., McDougal, R. A., Ding, H., Chan, D., Cai, Y., & Grutzendler, J. (2022) · Nature · doi:10.1038/s41586-022-05491-6 · Cited by 155
Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease
Zhao, R., Hu, W., Tsai, J., Li, W., & Gan, W.-B. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0188-6 · Cited by 151
Role of Microvascular Disruption in Brain Damage from Traumatic Brain Injury
Logsdon, A. F., Lucke-Wold, B. P., Turner, R. C., Huber, J. D., Rosen, C. L., & Simpkins, J. W. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140057 · Cited by 174
Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?
Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150
Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease
Cai, Z., Zhao, Y. C., & Zhao, B. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455386 · Cited by 149
Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms
Crish, S. D., & Calkins, D. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.036 · Cited by 144
The Role of Microglia in Synaptic Stripping and Synaptic Degeneration: A Revised Perspective
Perry, V. H., & O'Connor, V. M. (2010) · ASN NEURO · doi:10.1042/an20100024 · Cited by 131
Axonal degeneration as a therapeutic target in the CNS
Lingor, P., Koch, J. C., Tönges, L., & Bähr, M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1362-3 · Cited by 119
Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E., Dugas, J., Pizzo, M. E., DeVos, S. L., Earr, T. K., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00547-7 · Cited by 124
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
El Hajj, H., Savage, J. C., Bisht, K., Parent, M., Vallières, L., Rivest, S., & Tremblay, M.-È. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1473-9 · Cited by 119
Mechanisms of Axonal Spheroid Formation in Central Nervous System Wallerian Degeneration
Beirowski, B., Nógrádi, A., Babetto, E., Garcia-Alias, G., & Coleman, M. P. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181da84db · Cited by 104
Self-citationDefining the earliest pathological changes of Alzheimer's disease
Vickers, J. C., Mitew, S., Woodhouse, A., Fernández-Martos, C. M., Kirkcaldie, M. T., Canty, A. J., McCormack, G. H., & King, A. E. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151218150322 · Cited by 111
Romberg, C., Horner, A. E., Bussey, T. J., & Saksida, L. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.006 · Cited by 111
Axonal Degeneration in AD: The Contribution of Aβ and Tau
Salvadores, N., Gerónimo‐Olvera, C., & Court, F. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.581767 · Cited by 101
Whiteman, I. T., Gervasio, O. L., Cullen, K. M., Guillemin, G. J., Jeong, E. V., Witting, P. K., Antao, S. T., Minamide, L. S., Bamburg, J. R., & Goldsbury, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3531-09.2009 · Cited by 92
Montero‐Crespo, M., Domínguez-Álvaro, M., Alonso‐Nanclares, L., DeFelipe, J., & Blázquez‐Llorca, L. (2020) · Brain · doi:10.1093/brain/awaa406 · Cited by 89
Reversible Axonal Dystrophy by Calcium Modulation in Frataxin-Deficient Sensory Neurons of YG8R Mice
Mollá, B., Muñoz-Lasso, D. C., Riveiro, F., Bolinches-Amorós, A., Pallardó, F. V., Fernandez-Vilata, A., de la Iglesia-Vayá, M., Palau, F., & González‐Cabo, P. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00264 · Cited by 87
Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss
White, M. A., Lin, Z., Kim, E., Henstridge, C. M., Peña‐Altamira, E., Hunt, C. K., Burchill, E., Callaghan, I., Loreto, A., Brown-Wright, H., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0800-9 · Cited by 88
Early pro-inflammatory cytokine elevations in the DBA/2J mouse model of glaucoma
Wilson, G. N., Inman, D. M., Crish, S. D., Smith, M. A., & Crish, S. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0399-0 · Cited by 84
Prokop, A. (2013) · Neural Development · doi:10.1186/1749-8104-8-17 · Cited by 84
Crish, S. D., Smith, M. A., Inman, D. M., Wilson, G. N., Young, J. W., & Crish, S. D. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00290 · Cited by 82
Intake of ω-6 Polyunsaturated Fatty Acid-Rich Vegetable Oils and Risk of Lifestyle Diseases
Yamashima, T., Ota, T., Mizukoshi, E., Nakamura, H., Yamamoto, Y., Kikuchi, M., Yamashita, T., & Kaneko, S. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa072 · Cited by 78
Rupp, N. J., Wegenast‐Braun, B. M., Radde, R., Calhoun, M. E., & Jucker, M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.014 · Cited by 77
Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75
Coomaraswamy, J., Kilger, E., Wölfing, H., Schäfer, C., Kaeser, S. A., Wegenast‐Braun, B. M., Hefendehl, J. K., Wolburg, H., Mazzella, M. J., Ghiso, J. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001056107 · Cited by 74
Axonal degeneration induced by glutamate excitotoxicity is mediated by necroptosis
Hernández, D. E., Salvadores, N., Moya‐Alvarado, G., Catalán, R. J., Bronfman, F. C., & Court, F. A. (2018) · Journal of Cell Science · doi:10.1242/jcs.214684 · Cited by 75
Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system
Vickers, J. C., King, A. E., Woodhouse, A., Kirkcaldie, M. T., Staal, J. A., McCormack, G. H., Blizzard, C. A., Musgrove, R. E. J., Mitew, S., Liu, Y., et al. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.004 · Cited by 69
Xu, Q., Su, Z., Yang, W., Zhong, M., Xian, Y., & Lin, Z. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02704-1 · Cited by 72
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
Balusu, S., & Strooper, B. D. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02747-5 · Cited by 76
Crish, S. D., Dapper, J. D., MacNamee, S. E., Balaram, P., Sidorova, T. N., Lambert, W. S., & Calkins, D. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.069 · Cited by 69
Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus‐Merzbacher disease
Edgar, J. M., McCulloch, M. C., Montague, P., Brown, A. M., Thilemann, S., Pratola, L., Gruenenfelder, F. I., Griffiths, I. R., & Nave, K. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.200900057 · Cited by 71
Jackson, H. M., Soto, I., Graham, L. C., Carter, G. W., & Howell, G. R. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-831 · Cited by 66
Poon, C., Pellow, C., & Hynynen, K. (2020) · Theranostics · doi:10.7150/thno.52710 · Cited by 70
Amyloid-β plaques disrupt axon initial segments
Marin, M. A., Ziburkus, J., Jankowsky, J. L., & Rasband, M. N. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.04.018 · Cited by 72
Synaptic pathology in the cerebellar dentate nucleus in chronic multiple sclerosis
Albert, M., Barrantes-Freer, A., Lohrberg, M., Antel, J. P., Prineas, J. W., Palkovits, M., Wolff, J. R., Brück, W., & Stadelmann, C. (2017) · Brain Pathology · doi:10.1111/bpa.12450 · Cited by 65
Hahn, I., Voelzmann, A., Liew, Y.-T., Costa-Gomes, B., & Prokop, A. (2019) · Neural Development · doi:10.1186/s13064-019-0134-0 · Cited by 66
High plasticity of axonal pathology in Alzheimer’s disease mouse models
Blázquez‐Llorca, L., Valero-Freitag, S., Rodrigues, E. F., Merchán-Pérez, Á., Rodríguez, J., Dorostkar, M. M., DeFelipe, J., & Herms, J. W. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0415-y · Cited by 64
Neuritic Plaques — Gateways to Understanding Alzheimer’s Disease
Tsering, W., & Prokop, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03736-7 · Cited by 59
Mokhtar, S., Bakhuraysah, M. M., Cram, D. S., & Petratos, S. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/910502 · Cited by 60
Neuronal endoplasmic reticulum stress in axon injury and neurodegeneration
Li, S., Liu, Y., Selzer, M. E., & Hu, Y. (2013) · Annals of Neurology · doi:10.1002/ana.24005 · Cited by 56
Prokop, A., Beaven, R., Qu, Y., & Sánchez‐Soriano, N. (2013) · Journal of Cell Science · doi:10.1242/jcs.126912 · Cited by 58
Durrant, C. S., & Coleman, M. P. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0110-7 · Cited by 55
In vivo imaging of axonal transport using MRI: aging and Alzheimer’s disease
Minoshima, S., & Cross, D. J. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0707-8 · Cited by 53
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Yao, Y., Ren, Z., Yang, R., Mei, Y., Dai, Y., Cheng, Q., Xu, C., Xu, X., Wang, S., Kim, K. M., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00918-z · Cited by 53
Romberg, C., McTighe, S. M., Heath, C. J., Whitcomb, D. J., Cho, K., Bussey, T. J., & Saksida, L. M. (2012) · Brain · doi:10.1093/brain/aws074 · Cited by 54
Messing, L., Decker, J. M., Joseph, M., Mandelkow�, E., & Mandelkow, E.-M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.024 · Cited by 48
Saiz‐Sánchez, D., Úbeda‐Bañón, I., de la Rosa‐Prieto, C., & Martı́nez-Marcos, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111889 · Cited by 45
Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies
Xhima, K., Markham-Coultes, K., Hahn Kofoed, R., Saragovi, H. U., Hynynen, K., & Aubert, I. (2022) · Brain · doi:10.1093/brain/awab460 · Cited by 43
Rönnbäck, A., Sagelius, H., Bergstedt, K. D., Näslund, J., Westermark, G. T., Winblad, B., & Graff, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.012 · Cited by 43
Morel, M., Héraud, C., Nicaise, C., Suain, V., & Brion, J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0901-4 · Cited by 43
Neuron–glia interactions underlie ALS-like axonal cytoskeletal pathology
King, A. E., Dickson, T. C., Blizzard, C. A., Woodhouse, A., Foster, S., Chung, R. S., & Vickers, J. C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.004 · Cited by 42
Mureşan, V., & Muresan, Z. L. (2009) · Future Neurology · doi:10.2217/fnl.09.54 · Cited by 41
Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin
Maulik, M., Ghoshal, B., Kim, J., Wang, Y., Yang, J., Westaway, D. A., & Kar, S. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds322 · Cited by 39
Xiao, A.-W., He, J., Wang, Q., Luo, Y., Sun, Y., Zhou, Y., Yang, G., Lucassen, P. J., & Dai, J. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1736-7 · Cited by 36
Extrusion of misfolded and aggregated proteins – a protective strategy of aging neurons?
Doehner, J., Genoud, C., Imhof, C., Krstic, D., & Knuesel, I. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08154.x · Cited by 35
Marangoni, M., Adalbert, R., Janečková, L., Patrick, J., Kohli, J. S., Coleman, M. P., & Conforti, L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.024 · Cited by 37
Kolaric, K. V., Thomson, G., Edgar, J. M., & Brown, A. M. (2013) · Physiological Reports · doi:10.1002/phy2.59 · Cited by 32
Zhang, J., Wu, N., Wang, S., Yao, Z., Xiao, F., Lu, J., & Chen, B. (2021) · Aging Cell · doi:10.1111/acel.13380 · Cited by 33
Smith, M. A., Xia, C. Z., Crish, S. D., Fening, K. M., Inman, D. M., Schofield, B. R., & Crish, S. D. (2016) · The Journal of Comparative Neurology · doi:10.1002/cne.24012 · Cited by 28
Abnormal Population Responses in the Somatosensory Cortex of Alzheimer’s Disease Model Mice
Maatuf, Y., Stern, E. A., & Slovin, H. (2016) · Scientific Reports · doi:10.1038/srep24560 · Cited by 34
Karati, D., Meur, S., Roy, S., Mukherjee, S., Debnath, B., Jha, S. K., Sarkar, B. K., Naskar, S., & Ghosh, P. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03500-1 · Cited by 31
Coleman, M. P. (2011) · Advances in genetics · doi:10.1016/b978-0-12-380860-8.00005-7 · Cited by 31
Age, Neuropathology, and Dementia
Chen, L.-W. (2009) · New England Journal of Medicine · doi:10.1056/nejmc091346 · Cited by 29
Central Visual Pathways in Glaucoma
Crish, S. D., & Calkins, D. J. (2015) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000291 · Cited by 27
Christensen, D. Z., Hüttenrauch, M., Mitkovski, M., Pradier, L., & Wirths, O. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00139 · Cited by 29
How neurons maintain their axons long-term: an integrated view of axon biology and pathology
Smith, G. A., Sweeney, S. T., O’Kane, C. J., & Prokop, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1236815 · Cited by 28
Cai, Y., Kanyo, J. E., Wilson, R. S., Bathla, S., Cardozo, P. L., Тонг, Л., Qin, S., Fuentes, L. A., Pinheiro‐de‐Sousa, I., Huynh, T., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00823-3 · Cited by 27
Sakakibara, Y., Hirota, Y., Ibaraki, K., Takei, K., Chikamatsu, S., Tsubokawa, Y., Saito, T., Saido, T. C., Sekiya, M., & Iijima, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210385 · Cited by 26
Proctor, C. J., Pienaar, I. S., Elson, J. L., & Kirkwood, T. B. L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-32 · Cited by 27
Adalbert, R., Milde, S., Durrant, C. S., Ando, K., Stygelbout, V., Yilmaz, Z., Gould, S. A., Brion, J., & Coleman, M. P. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.033 · Cited by 25
Maia, P. D., & Kutz, J. N. (2017) · Journal of Computational Neuroscience · doi:10.1007/s10827-017-0643-y · Cited by 24
Edgar, J. M., & Griffiths, I. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374709-9.00005-5 · Cited by 25
The challenges of axon survival: Introduction to the special issue on axonal degeneration
Coleman, M. P. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.06.007 · Cited by 22
Zhang, J., Long, B., Li, A., Sun, Q., Tian, J., Luo, T., Ding, Z., Gong, H., & Li, X. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.608177 · Cited by 22
Mitochondrial behavior when things go wrong in the axon
Devoto, V. M. P., Onyango, I. G., & Stokin, G. B. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.959598 · Cited by 24
Mitew, S., Kirkcaldie, M., Dickson, T. C., & Vickers, J. C. (2013) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2013.00030 · Cited by 22
Labour, M.-N., Vigier, S., Lerner, D. A., Marcilhac, A., & Belamie, E. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.04.001 · Cited by 22
Cai, Y., Xue, Z.-Q., Zhang, X.-M., Li, M.-R., Wang, H., Luo, X. G., Cai, H., & Yan, X.-X. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.043 · Cited by 21
Fathy, Y. Y., Jonkman, L. E., Bol, J. G. J. M., Timmermans, E., Jonker, A. J., Rozemüller, A. J. M., & van de Berg, W. D. J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00325-x · Cited by 21
Progressive sleep disturbance in various transgenic mouse models of Alzheimer’s disease
Drew, V. J., Wang, C., & Kim, T. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119810 · Cited by 19
Modelling early responses to neurodegenerative mutations in mice
Gilley, J., Adalbert, R., & Coleman, M. P. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390933 · Cited by 17
Chi, H., Lee, S., Shiu, R.-H., Han, R., Hsieh, C.-P., Wei, T.-M., Lo, C., Chang, H.-Y., & Sang, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-70423-1 · Cited by 17
Metadata
- Authors
- Adalbert, R., Nogradi, A., Babetto, E., Janeckova, L., Walker, S. A., Kerschensteiner, M., Misgeld, T., & Coleman, M. P.
- Affiliations
- Babraham Institute (GB)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-05
- Volume
- 132
- Issue
- 2
- Pages
- 402-416
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2161240378
- Cited by
- 177
- References
- 60
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 15 · 2021: 9 · 2020: 11 · 2019: 10 · 2018: 5 · 2017: 9 · 2016: 16 · 2015: 10 · 2014: 6 · 2013: 12 · 2012: 21
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (069652/Z/02/Z)
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, axonal dystrophy, amyloid plaques, synaptic loss, axonal degeneration, axonal transport, neuronal survival, therapeutic window
- MeSH terms
- Alzheimer Disease, Animals, Axons, Breeding, Cell Survival, Immunohistochemistry, Male, Mice, Inbred C57BL, Microscopy, Electron, Nerve Degeneration, Synaptic Transmission, Neurons, Models, Animal, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
